Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Understanding the differences between budgeting methods can help you choose the best approach. See how zero based budgeting stacks up.
22,683 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Industry chatter points to a late-2026 filing for a BlackRock XRP ETF, contingent on liquidity and demand. Six XRP ET...
Nvidia’s latest earnings release produced solid numbers, but traders say the real move will come from the March GTC. ...
Novo Nordisk signals a major Wegovy price cut set for January 2027, triggering a sharp market reaction as the stock s...
Photronics stock soared again after a solid Q1 2026 showing. This article breaks down the earnings beat, demand trend...
ZachXBT has named Axiom in a probe over alleged insider trading by an employee. Axiom paused internal tools and says ...
eXp World Holdings plans to reincorporate from Delaware to Texas, with a stockholder vote slated at the annual meetin...
As investors eye the next earnings cycle, Sweetgreen's 2025 earnings outlook becomes a focal point for growth, margin...
Bitcoin struggled to push past the $67K mark as Ethereum sales by Vitalik Buterin weigh on sentiment, while XRP spot ...
Bitcoin slips below key levels as geopolitical tensions flare, sparking a broad crypto retreat. Traders weigh risk an...
Polkadot is back in traders’ sights as cross-chain activity and parachain momentum intensify. Here's a fresh 2025–203...
Bitcoin extended its decline into a fifth straight month, posting double-digit losses in February as macro headwinds ...